Why Biologics' Middle Child Is Driving Biotech Growth
For decades, the pharmaceutical industry operated on a binary paradigm: small molecules and large biologics. Small molecules…
How Regulatory Shifts Are Redefining Pain Management in 2026
The global pain management landscape is undergoing its most significant transformation in decades. For years, the…
PVP Labs Invited to Present Taphalgin (Lumekefamide) at the 2026 Pain Therapeutics Summit Europe; Announces Key DEA Regulatory Determination
At PVP Labs, our mission has…
The integration of artificial intelligence into peptide design is rapidly reshaping the landscape of drug discovery. For decades, the pharmaceutical industry has grappled with a…
The peptide synthesis market is projected to reach over USD 1,066.7 million by 2032, reflecting robust growth driven by advances in peptide therapeutics and the…
Bioduro has announced the launch of a dedicated peptide business unit, marking a strategic expansion in their peptide research capabilities. This new unit is designed…